Neurology News & Articles

1 Serum iron levels and the risk of parkinson disease: A mendelian randomization study Full Text PLoS Medicine, June 13, 2013    Evidence Based Medicine    Clinical Article
Exclusive Author Commentary

2 Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD) Archives of Gerontology and Geriatrics, June 13, 2013    Review Article

3 Clock drawing test: is it useful for dementia screening in patients having parkinson disease with and without depression? Journal of Geriatric Psychiatry and Neurology, June 13, 2013    Clinical Article

4 Depressive symptoms in Parkinson’s disease and in non-neurological medical illnesses Full Text Neuropsychiatric Disease and Treatment, June 13, 2013    Clinical Article

5 Postural and intention tremors: Detailed clinical study of essential tremor vs. Parkinsons disease Frontiers in Neurology, June 13, 2013    Clinical Article

6 The Beneficial Role of Intensive Exercise on Parkinson Disease Progression American Journal of Physical Medicine & Rehabilitation, June 13, 2013    Clinical Article

7 Neurosteroid and neurotransmitter alterations in Parkinson’s disease Frontiers in Neuroendocrinology, June 13, 2013    Review Article

8 White-Matter Changes Correlate with Cognitive Functioning in Parkinsons Disease Frontiers in Neurology, June 13, 2013    Clinical Article

9 Cerebrospinal fluid levels of chromogranin A in the treatment-naïve early stage Parkinsons disease: a pilot study Journal of Neural Transmission, June 13, 2013    Clinical Article

10 Deep Brain Stimulation of the Subthalamic Nucleus Regulates Postabsorptive Glucose Metabolism in Patients With Parkinson's Disease Journal of Clinical Endocrinology and Metabolism, June 13, 2013    Review Article

11 CERAD test performance and cognitive impairment in Parkinsons disease Acta Neurologica Scandinavica, June 13, 2013    Clinical Article

12 Gray matter atrophy distinguishes between Parkinson disease motor subtypes Neurology, June 13, 2013    Review Article

13 Effect and safety of duodenal levodopa infusion in advanced Parkinsons disease: a retrospective multicenter outcome assessment in patient routine care Journal of Neural Transmission, June 13, 2013    Clinical Article

14 Valproic acid-induced parkinsonism: Levodopa responsiveness with dyskinesia Parkinsonism & Related Disorders, June 13, 2013    Clinical Article

15 Attenuated neural response to gamble outcomes in drug-naive patients with Parkinsons disease Brain, June 13, 2013    Review Article

16 Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinsons disease Brain, June 13, 2013    Review Article

17 Switch from selegiline to rasagiline is beneficial in patients with Parkinsons disease Journal of Neural Transmission, June 2, 2013    Clinical Article

18 A systematic review of biomarkers for disease progression in Parkinsons disease Full Text BMC Neurology, June 2, 2013    Clinical Article

19 Levodopa changes the severity of freezing in Parkinsons disease Parkinsonism & Related Disorders, June 2, 2013    Clinical Article

20 Pharmacokinetic Considerations for the Use of Levodopa in the Treatment of Parkinson Disease: Focus on Levodopa/Carbidopa/Entacapone for Treatment of Levodopa-Associated Motor Complications Clinical Neuropharmacology, June 2, 2013    Clinical Article

21 Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinsons disease Parkinsonism & Related Disorders, June 2, 2013    Clinical Article

22 Apathy in Patients With Parkinson Disease as a Function of Side of Onset Journal of Geriatric Psychiatry and Neurology, June 2, 2013    Clinical Article

23 Degradation of Stored Movement Representations in the Parkinsonian Brain and the Impact of Levodopa Neuropsychologia, June 2, 2013    Clinical Article

24 Cognitive correlates of visual hallucinations in non-demented Parkinsons disease patients Parkinsonism & Related Disorders, June 2, 2013    Review Article

25 Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease The Lancet Neurology, June 2, 2013    Clinical Article

26 Combined dementia-risk biomarkers in Parkinsons disease: A prospective longitudinal study Parkinsonism & Related Disorders, June 2, 2013    Clinical Article

27 What is the best treatment of drug-resistant trigeminal neuralgia in patients affected by multiple sclerosis- A literature analysis of surgical procedures Clinical Neurology and Neurosurgery, May 21, 2013    Clinical Article

28 The effects of long-term interferon- beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study Multiple Sclerosis Journal, May 21, 2013    Clinical Article

29 Sexual Disparities in the Incidence and Course of MS Clinical Immunology, May 21, 2013    Review Article

30 Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy Neurology, May 21, 2013    Clinical Article

31 The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis Brain, Behavior, and Immunity, May 21, 2013    Clinical Article

32 Role of oral teriflunomide in the management of multiple sclerosis Full Text Neuropsychiatric Disease and Treatment, May 21, 2013

33 Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis Brain, May 21, 2013    Clinical Article

34 Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples Multiple Sclerosis Journal, May 21, 2013    Clinical Article

35 Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort Multiple Sclerosis Journal, May 21, 2013    Clinical Article

36 Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study Neurology, May 21, 2013    Clinical Article

37 Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis Acta Neurologica Scandinavica, May 9, 2013    Clinical Article

38 β-synuclein aggregates and induces neurodegeneration in dopaminergic neurons Annals of Neurology , May 9, 2013    Review Article

39 Abnormal Interaction of Oligomeric Amyloid-β with Phosphorylated Tau: Implications for Neuronal Damage in Alzheimers Disease Journal of Alzheimer’s Disease, May 9, 2013    Clinical Article

40 Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinsons disease? Journal of Internal Medicine, April 28, 2013    Clinical Article

41 Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities The Lancet Neurology, April 28, 2013    Clinical Article

42 A two-year randomized controlled trial of progressive resistance exercise for Parkinsons disease Movement Disorders, April 28, 2013    Clinical Article

43 Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinsons disease - A randomized study Parkinsonism & Related Disorders, April 28, 2013    Clinical Article

44 Often overlooked neuropsychiatric syndromes in Parkinson's disease Full Text British Journal of Medical Practitioners, April 28, 2013    Review Article

45 Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinsons disease European Journal of Neurology, April 28, 2013    Review Article

46 Mesenchymal stem cells and neuroregeneration in Parkinson's disease Experimental Neurology, April 28, 2013    Review Article

47 Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinsons disease Movement Disorders, April 28, 2013    Clinical Article

48 Rotigotine and specific non-motor symptoms of Parkinsons disease: Post hoc analysis of RECOVER Parkinsonism & Related Disorders, April 16, 2013    Clinical Article

49 The relationship between balance control and vitamin D in Parkinsons disease--a pilot study Movement Disorders, April 16, 2013    Clinical Article

50 Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia? Full Text BMC Medicine, April 16, 2013

51 Prescription of drugs with potential adverse effects on cardiac conduction in Parkinsons disease Parkinsonism & Related Disorders, April 16, 2013    Clinical Article

52 Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes Journal of Neurology, Neurosurgery & Psychiatry, April 16, 2013    Clinical Article

53 Risk factors for hallucinations in Parkinsons disease: Results from a large prospective cohort study Movement Disorders, April 16, 2013    Clinical Article

54 Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course Journal of Neuroimmunology, April 5, 2013    Clinical Article

55 Cognitive impairment differs between primary progressive and relapsing-remitting MS Neurology, April 5, 2013    Clinical Article

1 Aspirin nonresponders in patients with ischaemic stroke Blood Coagulation & Fibrinolysis, May 14, 2013

2 Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials International Journal of Stroke, May 23, 2013

3 Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia – open-label trial Acta Neurologica Scandinavica, May 17, 2013

4 Treatment with statins and ischemic stroke severity Neurology, April 25, 2013

5 Effectiveness of antidementia drugs in delaying Alzheimers disease progression Alzheimer's & Dementia, May 2, 2013

6 Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials The Lancet Neurology, May 17, 2013    Evidence Based Medicine    Review Article

7 Oxcarbazepine for neuropathic pain Cochrane Reviews, April 2, 2013    Review Article

8 The relationship between serum levels of vitamin D and migraine Journal of Research in Medical Sciences, March 12, 2013    Evidence Based Medicine

9 Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation Stroke, May 29, 2013

10 Potential impact of new oral anticoagulants on the management of atrial fibrillation-related stroke in primary care International Journal of Clinical Practice, May 7, 2013

11 Operative mortality and stroke after on-pump vs off-pump surgery in high-risk patients: an analysis of 83 914 coronary bypass operations European Journal of Cardio-Thoracic Surgery, May 20, 2013

12 New Evidence for Therapies in Stroke Rehabilitation Current Atherosclerosis Reports, May 3, 2013    Evidence Based Medicine    Review Article

13 The effects of long-term interferon- beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study Multiple Sclerosis Journal, May 10, 2013

14 Headaches during pregnancy Clinical Obstetrics and Gynecology, May 8, 2013

15 Atrial fibrillation in young stroke patients European Journal of Neurology, May 22, 2013

16 Aspirin with or without an antiemetic for acute migraine headaches in adults Cochrane Reviews, May 10, 2013    Evidence Based Medicine

17 Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimers disease Alzheimer's & Dementia, May 13, 2013    Review Article

18 Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): Protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36·5°C or above International Journal of Stroke, May 28, 2013

19 Inhaled Sevoflurane May Promote Progression of Amnestic Mild Cognitive Impairment: A Prospective, Randomized Parallel-Group Study The American Journal of the Medical Sciences, April 23, 2013

20 Dietary calcium intake and risk of stroke: a dose-response meta-analysis American Journal of Clinical Nutrition, April 5, 2013    Evidence Based Medicine